Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesunate, France, 2011-2013

被引:51
作者
Jaureguiberry, Stephane [1 ,2 ,3 ]
Thellier, Marc [1 ,2 ,3 ]
Ndour, Papa Alioune [1 ]
Ader, Flavie [2 ]
Roussel, Camille [1 ]
Sonneville, Romain [4 ]
Mayaux, Julien [2 ]
Matheron, Sophie [4 ]
Angoulvant, Adela [5 ,6 ]
Wyplosz, Benjamin [6 ]
Rapp, Christophe [7 ]
Pistone, Thierry [8 ]
Lebrun-Vignes, Benedicte [2 ]
Kendjo, Eric [3 ]
Danis, Martin [1 ,2 ,3 ]
Houze, Sandrine [4 ]
Bricaire, Francois [2 ]
Mazier, Dominique [1 ,2 ,3 ]
Buffet, Pierre [1 ,2 ,3 ]
Caumes, Eric [1 ,2 ]
机构
[1] Univ Paris 06, Paris, France
[2] Hop La Pitie Salpetriere, AP HP, F-75013 Paris, France
[3] Ctr Natl Reference Paludisme, Paris, France
[4] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France
[5] Univ Paris 11, Orsay, France
[6] Hop Bicetre, AP HP, Le Kremlin Bicetre, France
[7] Hosp Instruct Armees Begin, St Mande, France
[8] Hop Pellegrin, F-33076 Bordeaux, France
关键词
SEVERE FALCIPARUM-MALARIA; SEVERE IMPORTED MALARIA; INTRAVENOUS ARTESUNATE; AFRICAN CHILDREN; QUININE;
D O I
10.3201/eid2105.141171
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Artesunate is the most effective treatment for severe malaria. However, delayed-onset hemolytic anemia has been observed in approximate to 20% of travelers who receive artesunate, approximate to 60% of whom require transfusion. This finding could discourage physicians from using artesunate. We prospectively evaluated a cohort of 123 patients in France who had severe imported malaria that was treated with artesunate; our evaluation focused on outcome, adverse events, and postartesunate delayed-onset hemolysis (PADH). Of the 123 patients, 6 (5%) died. Overall, 97 adverse events occurred. Among the 78 patients who received follow-up for >8 days after treatment initiation, 76 (97%) had anemia, and 21(27%) of the 78 cases were recorded as PADH. The median drop in hemoglobin levels was 1.3 g/dL; 15% of patients with PADH had hemoglobin levels of <7 g/dL, and 1 required transfusion. Despite the high incidence of PADH, the resulting anemia remained mild in 85% of cases. This reassuring result confirms the safety and therapeutic benefit of artesunate.
引用
收藏
页码:804 / 812
页数:9
相关论文
共 37 条
[11]   Severe Imported Falciparum Malaria: A Cohort Study in 400 Critically Ill Adults [J].
Bruneel, Fabrice ;
Tubach, Florence ;
Corne, Philippe ;
Megarbane, Bruno ;
Mira, Jean-Paul ;
Peytel, Eric ;
Camus, Christophe ;
Schortgen, Frederique ;
Azoulay, Elie ;
Cohen, Yves ;
Georges, Hugues ;
Meybeck, Agnes ;
Hyvernat, Herve ;
Trouillet, Jean-Louis ;
Frenoy, Eric ;
Nicolet, Laurent ;
Roy, Carine ;
Durand, Remy ;
Le Bras, Jacques ;
Wolff, Michel .
PLOS ONE, 2010, 5 (10)
[12]   Ex vivo perfusion of human spleens maintains clearing and processing functions [J].
Buffet, PA ;
Milon, G ;
Brousse, V ;
Correas, JM ;
Dousset, B ;
Couvelard, A ;
Kianmanesh, R ;
Farges, O ;
Sauvanet, A ;
Paye, F ;
Ungeheuer, MN ;
Ottone, C ;
Khun, H ;
Fiette, L ;
Guigon, G ;
Huerre, M ;
Mercereau-Puijalon, O ;
David, PH .
BLOOD, 2006, 107 (09) :3745-3752
[13]   The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology [J].
Buffet, Pierre A. ;
Safeukui, Innocent ;
Deplaine, Guillaume ;
Brousse, Valentine ;
Prendki, Virginie ;
Thellier, Marc ;
Turner, Gareth D. ;
Mercereau-Puijalon, Odile .
BLOOD, 2011, 117 (02) :381-392
[14]   Severe malaria, artesunate and haemolysis [J].
Caramello, Pietro ;
Balbiano, Rosanna ;
De Blasi, Tiziano ;
Chiriotto, Monica ;
Deagostini, Maura ;
Calleri, Guido .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (08) :2053-2054
[15]   The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria [J].
Chotivanich, K ;
Udomsangpetch, R ;
Dondorp, A ;
Williams, T ;
Angus, B ;
Simpson, JA ;
Pukrittayakamee, S ;
Looareesuwan, S ;
Newbold, CI ;
White, NJ .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (02) :629-633
[16]   Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine [J].
Corpolongo, Angela ;
De Nardo, Pasquale ;
Ghirga, Piero ;
Gentilotti, Elisa ;
Bellagamba, Rita ;
Tommasi, Chiara ;
Paglia, Maria Grazia ;
Nicastri, Emanuele ;
Narciso, Pasquale .
MALARIA JOURNAL, 2012, 11
[17]   Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial [J].
Dondorp, Arjen M. ;
Fanello, Caterina I. ;
Hendriksen, Ilse C. E. ;
Gomes, Ermelinda ;
Seni, Amir ;
Chhaganlal, Kajal D. ;
Bojang, Kalifa ;
Olaosebikan, Rasaq ;
Anunobi, Nkechinyere ;
Maitland, Kathryn ;
Kivaya, Esther ;
Agbenyega, Tsiri ;
Nguah, Samuel Blay ;
Evans, Jennifer ;
Gesase, Samwel ;
Kahabuka, Catherine ;
Mtove, George ;
Nadjm, Behzad ;
Deen, Jacqueline ;
Amumpaire, Juliet Mwanga ;
Nansumba, Margaret ;
Karema, Corine ;
Umulisa, Noella ;
Uwimana, Aline ;
Mokuolu, Olugbenga A. ;
Adedoyin, Olanrewaju T. ;
Johnson, Wahab B. R. ;
Tshefu, Antoinette K. ;
Onyamboko, Marie A. ;
Sakulthaew, Tharisara ;
Ngum, Wirichada Pan ;
Silamut, Kamolrat ;
Stepniewska, Kasia ;
Woodrow, Charles J. ;
Bethell, Delia ;
Wills, Bridget ;
Oneko, Martina ;
Peto, Tim E. ;
von Seidlein, Lorenz ;
Day, Nicholas P. J. ;
White, Nicholas J. .
LANCET, 2010, 376 (9753) :1647-1657
[18]   Case Report: Artesunate for Severe Acute Plasmodium falciparum Infection in a Patient with Myasthenia Gravis [J].
Dournon, Nathalie ;
Buffet, Pierre ;
Caumes, Eric ;
Clair, Bernard ;
Jaureguiberry, Stephane .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2012, 87 (03) :435-436
[19]   Intravenous artesunate versus intravenous quinine in the treatment of severe falciparum malaria: a retrospective evaluation from a UK centre [J].
Eder, Marcus ;
Farne, Hugo ;
Cargill, Tamsin ;
Abbara, Aula ;
Davidson, Robert N. .
PATHOGENS AND GLOBAL HEALTH, 2012, 106 (03) :181-187
[20]  
Faiz MA, 2005, LANCET, V366, P717